On (b)(6) 2022, a male patient, who had previously undergone transurethral resection of the prostate (turp) surgical procedure, underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).On (b)(6) 2023, procept biorobotics corporation became aware that the patient was having difficulty voiding.A cystoscopy procedure revealed remnant tissue was left behind during the aquablation procedure, which created adhesions.The patient will need to undergo an additional procedure to address this issue.Upon review of the treatment log files for this event, the treating surgeon was coached on adequate cystoscopy placement to ensure proper apical treatment during aquablation therapy.No malfunction of the aquabeam robotic system was reported due to this event.
|
The device was not returned for investigation because it is a reusable component, which is still being used at the user facility.The investigation of this event consisted of the information received plus a review of the event log file, labeling, and dhr.The aquabeam robotic system's treatment logs file was reviewed, which confirmed no malfunctions during the aquablation procedure.The review of the treatment logs indicated that the system functioned as designed.A review of the device history record (dhr) ab2000-b / serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 4.3.Warnings: procedure as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: urinary retention.A root cause for the reported event could not be established.The aquabeam robotic system instructions for use list urinary retention as a potential risk of the aquablation procedure.Upon review of the treatment log files for this event, the treating surgeon was coached on adequate cystoscopy placement to ensure proper apical treatment during aquablation therapy.Based on the information received, plus a review of the event log file, ifu, and dhr, the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|